Publications

5808 Results

Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in acute myeloid leukaemia by reducing relapse risk: A source data meta-analysis of randomised trials in adults

Authors
R Hills;S Castaigne;F Appelbaum;J Delaunay;S Petersdorf;M Othus;E Estey;H Dombret;S Chevret;N Ifrah;J-Y Cahn;C Recher;L Chilton;A Moorman;A Burnett
Journal / Conference
Lancet Oncology 15(9):986-996
Year
2014
Research Committee(s)
Leukemia
PMID
PMID25008258
PMC
PMC4137593
Study Number(s)
S0106

NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report

Authors
F Ostronoff;M Othus;RB Gerbing;MR Loken;SC Raimondi;BA Hirsch;BJ Lange;S Petersdorf;J Radich;F Appelbaum;AS Gamis;T Alonzo;S Meshinchi
Journal / Conference
Blood 124(15):2400-2407;
Year
2014
Research Committee(s)
Leukemia
PMID
PMID25145343
PMC
PMC4192751
Study Number(s)
S0106

EGFR expression is associated with decreased benefit from trastuzumab in the NCCTG N9831 (Alliance) trial

Authors
H Cheng;K Ballman;M Vassilakopoulou;AC Dueck;MM Reinholz;K Tenner;J Gralow;C Hudis;NE Davidson;G Fountzilas;A McCullough;B Chen;A Psyrri;D Rimm;EA Perez
Journal / Conference
British Journal of Cancer 111(6):1065-1071;
Year
2014
Research Committee(s)
Breast
PMID
PMID25117817
PMC
PMC4453859
Study Number(s)
N9831

Empiric definition of eligibility criteria for clinical trials in relapsed/refractory AML: analysis of 1,892 patients from HOVON/SAKK and SWOG

Authors
R Walter;M Othus;B Lowenberg;G Ossenkoppele;S Petersdorf;T Pabst;MC Vekemans;F Appelbaum;H Erba;E Estey
Journal / Conference
Blood 124(21):3676; American Society for Hematology (December 6-9, 2014, San Francisco, CA), poster;
Year
2014
Research Committee(s)
Leukemia
Study Number(s)
S0106

Favorable outcomes for adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL): early results of US intergroup trial CALGB 10403 (Alliance)

Authors
W Stock;S Geyer;S Luger;A Advani;R Harvey;C Mullighan;C Willman;E August Parker;K Laumann;BL Sanford;G Marcucci;E Paietta;MS Tallman;FR Appelbaum;HP Erba;M Litzow;R Stone;RA Larson
Journal / Conference
Blood 124(21):796;American Society for Hematology (December 6-9, 2014, San Francisco, CA), oral;
Year
2014
Research Committee(s)
Leukemia
Study Number(s)
C10403

Determinants of fatal bleeding during induction chemotherapy for acute promyelocytic leukemia in the ATRA era

Authors
S Mantha;DA Goldman;J-W Lee;D Zannino;D Douer;H Iland;MR Litzow;EM Stein;FR Appelbaum;RA Larson;JM Rowe;MS Tallman
Journal / Conference
Blood 124(21):948; American Society for Hematology (December 6-9, 2014, San Francisco, CA), poster;
Year
2014
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9129 (INT-0129)

Telomere length recovery strongly predicts overall survival in acute promyelocytic leukemia (http://www.bloodjournal.org/content/124/21/2375)

Authors
M Baljevic;B Dumitriu;J-W Lee;E Paietta;J Racevskis;C Chen;E Stein;RE Gallagher;JM Rowe;F Appelbaum;B Powell;RA Larson;NS Young;M Tallman
Journal / Conference
Blood 124(21):2375; American Society for Hematology (December 6-9, 2014, San Francisco, CA), poster;
Year
2014
Research Committee(s)
Leukemia
Study Number(s)
C9710, SWOG-9129 (INT-0129)

SWOG S0410/CTN 0703: A phase II trial of tandem autologous stem cell transplantation (AHCT) for patients with primary progressive or recurrent Hodgkin lymphoma (HL) (ClinicalTrials.gov Identifier: NCT00233987)

Authors
E Smith;H Li;JW Friedberg;LS Constine;LM Rimsza;GG Laport;LL Popewell;DG Maloney;M Leblanc;SJ Forman;RI Fisher;P Stiff
Journal / Conference
Blood 124(21):676; American Society for Hematology (December 6-9, 2014, San Francisco, CA), oral;
Year
2014
Research Committee(s)
Lymphoma
Study Number(s)
S0410

Long term follow up of SWOG S0313: Ibritumomab Tiuxetan consolidation after 3 cycles of CHOP plus radiotherapy for high risk limited stage aggressive B-cell lymphoma (http://www.bloodjournal.org/content/124/21/4414)

Authors
DO Persky;TP Miller;JM Unger;CM Spier;S Puvvada;BD Stea;OW Press;LS Constine;KP Barton;M Leblanc;S Smith;RI Fisher;JW Friedberg
Journal / Conference
Blood 124(21):4414; American Society for Hematology (December 6-9, 2014, San Francisco, CA), poster;
Year
2014
Research Committee(s)
Lymphoma
Study Number(s)
S0313

Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for previously untreated mantle cell lymphoma: SWOG 0601

Authors
B Till;H Li;S Bernstein;RI Fisher;WR Burack;L Rimsza;JD Floyd;M DaSilva;D Moore;M Leblanc;JW Friedberg
Journal / Conference
Blood 124(21):149, 2014; American Society for Hematology (December 6-9, 2014, San Francisco, CA), oral;
Year
2014
Research Committee(s)
Lymphoma
Study Number(s)
S0601